Chemistry, manufacturing and controls (CMC) are an integral step in creating an effective biological product — and a crucial element of an effective biologics regulatory submission. CMC activities ...

The market opportunity lies in offering specialized training and consultancy services to pharmaceutical companies for navigating complex CMC regulatory requirements for biological drugs, ensuring ...

All stages of the drug development lifecycle require the proper adherence to regulatory chemistry, manufacturing and control (CMC) requirements. Join this two-day workshop for an overview of CMC ...

Learn how integrated development strategies, advanced technology platforms, and a robust CMC framework enable faster progression from DNA to IND and BLA.

This webinar explores an integrated approach to mAb development that embeds manufacturability, scalability, lifecycle ...

Dr. Olga Paley, Director of Bioprocess Development at Takeda, will discuss “Advancing Takeda’s Bioprocessing Platforms in Support of Clinical and Commercial Drug Supply” about the Chemistry, ...

At a conference early next year, biologics manufacturers will be encouraged to develop a chemistry, manufacturing, and controls (CMC) management strategy for their reference material early in ...

CMC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, and River Vision Development Corporation (River Vision), a private company focused on ophthalmology, ...

Toronto, Ontario and Haifa, Israel--(Newsfile Corp. - February 10, 2026) - NurExone Biologic Inc. (NRX:CA) (OTCQB: NRXBF) (FSE: J90) ("NurExone" or the "Company"), a ...

* Portola Pharmaceuticals- pursuant to agreement, cmc will provide other services supporting co's regulatory applications in United States, European Union * Portola Pharmaceuticals Inc- under ...